Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study

NCT00443105 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER_GOV

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Tacrolimus 0.03% ointment (Protopic)

Sponsor

Assaf-Harofeh Medical Center